Name | Number of supported studies | Average coverage | |
---|---|---|---|
kidney loop of Henle epithelial cell | 4 studies | 49% ± 28% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
kidney | 3 studies | 24% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 1477.95 | 328 / 328 | 79% | 8.65 | 140 / 178 |
kidney | 100% | 2397.30 | 89 / 89 | 23% | 1.12 | 211 / 901 |
liver | 87% | 36.52 | 197 / 226 | 5% | 0.31 | 22 / 406 |
spleen | 84% | 61.11 | 203 / 241 | 0% | 0 | 0 / 0 |
ovary | 76% | 144.83 | 136 / 180 | 7% | 0.19 | 30 / 430 |
bladder | 76% | 81.33 | 16 / 21 | 2% | 0.08 | 11 / 504 |
stomach | 64% | 18.12 | 229 / 359 | 1% | 0.05 | 4 / 286 |
intestine | 49% | 13.60 | 477 / 966 | 4% | 0.35 | 21 / 527 |
thymus | 38% | 207.41 | 247 / 653 | 2% | 0.09 | 11 / 605 |
prostate | 35% | 6.42 | 85 / 245 | 0% | 0 | 0 / 502 |
peripheral blood | 31% | 21.97 | 289 / 929 | 0% | 0 | 0 / 0 |
adrenal gland | 28% | 4.36 | 73 / 258 | 1% | 0.27 | 3 / 230 |
lung | 22% | 4.43 | 127 / 578 | 5% | 0.34 | 54 / 1155 |
brain | 17% | 7.36 | 450 / 2642 | 0% | 0 | 0 / 705 |
esophagus | 9% | 1.15 | 125 / 1445 | 2% | 0.21 | 3 / 183 |
skin | 3% | 0.35 | 53 / 1809 | 1% | 0.03 | 5 / 472 |
adipose | 4% | 0.82 | 44 / 1204 | 0% | 0 | 0 / 0 |
uterus | 2% | 0.31 | 4 / 170 | 1% | 0.14 | 5 / 459 |
breast | 3% | 0.36 | 14 / 459 | 0% | 0.00 | 1 / 1118 |
eye | 0% | 0 | 0 / 0 | 3% | 0.05 | 2 / 80 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.07 | 1 / 45 |
blood vessel | 2% | 0.26 | 26 / 1335 | 0% | 0 | 0 / 0 |
muscle | 1% | 0.12 | 10 / 803 | 0% | 0 | 0 / 0 |
heart | 1% | 0.07 | 6 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1901653 | Biological process | cellular response to peptide |
GO_0007254 | Biological process | JNK cascade |
GO_0071333 | Biological process | cellular response to glucose stimulus |
GO_0002931 | Biological process | response to ischemia |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0048754 | Biological process | branching morphogenesis of an epithelial tube |
GO_0051924 | Biological process | regulation of calcium ion transport |
GO_0071305 | Biological process | cellular response to vitamin D |
GO_0007635 | Biological process | chemosensory behavior |
GO_0035729 | Biological process | cellular response to hepatocyte growth factor stimulus |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0045907 | Biological process | positive regulation of vasoconstriction |
GO_0006874 | Biological process | intracellular calcium ion homeostasis |
GO_0032024 | Biological process | positive regulation of insulin secretion |
GO_0070509 | Biological process | calcium ion import |
GO_0071774 | Biological process | response to fibroblast growth factor |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0071404 | Biological process | cellular response to low-density lipoprotein particle stimulus |
GO_0060613 | Biological process | fat pad development |
GO_1902476 | Biological process | chloride transmembrane transport |
GO_0007193 | Biological process | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway |
GO_0009653 | Biological process | anatomical structure morphogenesis |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0001503 | Biological process | ossification |
GO_0050927 | Biological process | positive regulation of positive chemotaxis |
GO_0042311 | Biological process | vasodilation |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0032782 | Biological process | bile acid secretion |
GO_0090280 | Biological process | positive regulation of calcium ion import |
GO_0005513 | Biological process | detection of calcium ion |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0043679 | Cellular component | axon terminus |
GO_0043025 | Cellular component | neuronal cell body |
GO_0009986 | Cellular component | cell surface |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0005178 | Molecular function | integrin binding |
GO_0004435 | Molecular function | phosphatidylinositol phospholipase C activity |
GO_0016597 | Molecular function | amino acid binding |
GO_0044325 | Molecular function | transmembrane transporter binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CASR |
Protein name | Extracellular calcium-sensing receptor (CaR) (CaSR) (hCasR) (Parathyroid cell calcium-sensing receptor 1) (PCaR1) Calcium sensing receptor Extracellular calcium-sensing receptor |
Synonyms | PCAR1 GPRC2A |
Description | FUNCTION: G-protein-coupled receptor that senses changes in the extracellular concentration of calcium ions and plays a key role in maintaining calcium homeostasis . Senses fluctuations in the circulating calcium concentration and modulates the production of parathyroid hormone (PTH) in parathyroid glands (By similarity). The activity of this receptor is mediated by a G-protein that activates a phosphatidylinositol-calcium second messenger system . The G-protein-coupled receptor activity is activated by a co-agonist mechanism: aromatic amino acids, such as Trp or Phe, act concertedly with divalent cations, such as calcium or magnesium, to achieve full receptor activation . . |
Accessions | Q2F3K5 Q2F3K6 P41180 Q2F3K1 Q2F3K3 Q2F3K4 B6VB31 A0A1X7SBX3 ENST00000639785.2 [P41180-1] Q2F3K2 ENST00000490131.7 ENST00000498619.4 [P41180-2] ENST00000638421.1 [P41180-1] Q86UN7 |